header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Knee

CHANGE IN SKIN TEMPERATURE OF THE KNEE WHEN USING DIFFERENT TEMPERATURE SETTINGS ON A CRYOCOMPRESSION DEVICE: A RANDOMIZED CROSSOVER TRIAL

The British Association for Surgery of the Knee (BASK) May 2022 Meeting, Newport, Wales, 17–18 May 2022.



Abstract

Abstract

Introduction

Cryocompression therapy after knee surgery is widely utilised for post-operative rehabilitation. Skin temperature should be reduced to 10–15°C to maximise the therapeutic benefits while avoiding risks of adverse events. Some cryocompression devices offer control over the temperature of the ice-water circulated through a cuff. The degree to which this corresponds to the achieved skin temperature during a treatment is unknown.

Methods

30 healthy participants volunteered for this prospective randomised crossover trial involving the use of a cryocompression device. Each underwent a 30-minute test in all of five conditions: A, B, C, D and Control. Conditions corresponded to device temperature settings of 6, 8, 10, 12°C and no ice-water circulation, respectively. Skin temperature was measured prior to the cuff being applied, then every 5 minutes during a test.

Results

Groups A, B, C and D significantly reduced skin temperature relative to the Control condition (p<0.05). Mean baseline skin temperatures did not significantly differ between groups. Mean skin temperatures after 30 minutes were 13.2 ± 1.9°C (Group A), 14.4 ± 1.5°C (Group B), 16.3 ± 1.8°C (Group C), 18.3 ± 1.7°C (Group D), and 30.8 ± 2.3°C (Control).

Conclusions

The cryocompression device successfully reduced the skin temperature to within the therapeutic range. However, temperature settings did not correspond to skin temperatures achieved. To optimise the therapeutic benefit of treatment with this device, the 6°C setting is recommended. (Note: these are preliminary results from on an ongoing study, comprising 72% of the final dataset. Full results will be presented at BASK 2022).